ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Rigel Pharmaceuticals Inc

Rigel Pharmaceuticals Inc (RIGL)

27.61
-0.27
(-0.97%)
Closed November 30 4:00PM
27.61
0.00
(0.00%)
After Hours: 3:59PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
27.61
Bid
25.80
Ask
28.11
Volume
97,549
27.21 Day's Range 28.155
7.4843 52 Week Range 29.82
Market Cap
Previous Close
27.88
Open
28.06
Last Trade
2
@
26.71
Last Trade Time
Financial Volume
$ 2,698,904
VWAP
27.6672
Average Volume (3m)
206,703
Shares Outstanding
17,615,040
Dividend Yield
-
PE Ratio
-19.38
Earnings Per Share (EPS)
-1.42
Revenue
116.88M
Net Profit
-25.09M

About Rigel Pharmaceuticals Inc

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For mor... Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit https://www.rigel.com/. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Rigel Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RIGL. The last closing price for Rigel Pharmaceuticals was $27.88. Over the last year, Rigel Pharmaceuticals shares have traded in a share price range of $ 7.4843 to $ 29.82.

Rigel Pharmaceuticals currently has 17,615,040 shares outstanding. The market capitalization of Rigel Pharmaceuticals is $491.11 million. Rigel Pharmaceuticals has a price to earnings ratio (PE ratio) of -19.38.

RIGL Latest News

Rigel to Present at the Jefferies London Healthcare Conference

Rigel to Present at the Jefferies London Healthcare Conference PR Newswire SOUTH SAN FRANCISCO, Calif., Nov. 12, 2024 SOUTH SAN FRANCISCO, Calif., Nov. 12, 2024 /PRNewswire/ -- Rigel...

Rigel Reports Third Quarter 2024 Financial Results and Provides Business Update

Rigel Reports Third Quarter 2024 Financial Results and Provides Business Update PR Newswire SOUTH SAN FRANCISCO, Calif., Nov. 7, 2024 Third quarter total revenue of $55.3 million, which includes...

Rigel Announces Six Poster Presentations at the 66th American Society of Hematology Annual Meeting and Exposition

Rigel Announces Six Poster Presentations at the 66th American Society of Hematology Annual Meeting and Exposition PR Newswire SOUTH SAN FRANCISCO, Calif., Nov. 5, 2024 -Β  Β  Initial data from the...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
12.278.9581689029225.3428.0525.0417278526.73982057CS
413.86100.813.7529.8213.636831303023.86729887CS
1214.4121109.19994847713.197929.8212.6620670319.52835902CS
2618.31196.881720439.329.827.484347132811.317385CS
5217.21165.48076923110.429.827.484384179012.2276054CS
156-0.09-0.32490974729227.735.156.4220321114.00795793CS
2604.3118.497854077323.3556.4247631822.84757236CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BSLKBolt Projects Holdings Inc
$ 0.71
(139.86%)
80.81M
PRZOParaZero Technologies Ltd
$ 1.24
(94.14%)
205.02M
AIEVThunder Power Holdings Inc
$ 0.47
(87.25%)
122.71M
PASGPassage Bio Inc
$ 1.13
(69.52%)
15.44M
EPOWSunrise New Energy Company Ltd
$ 1.06
(45.21%)
314.9k
APLTApplied Therapeutics Inc
$ 2.03
(-76.31%)
43.9M
TGLTreasure Global Inc
$ 0.2944
(-29.08%)
1.85M
PROCProcaps Group SA
$ 1.51
(-27.75%)
106.08k
SHOTWSafety Shot Inc
$ 0.104
(-20.00%)
1.43k
MONDMondee Holdings Inc
$ 0.7102
(-19.59%)
297.63k
PRZOParaZero Technologies Ltd
$ 1.24
(94.14%)
205.02M
NVDANVIDIA Corporation
$ 138.25
(2.15%)
141.86M
AIEVThunder Power Holdings Inc
$ 0.47
(87.25%)
122.71M
RGTIRigetti Computing Inc
$ 3.05
(27.08%)
116.98M
MARAMARA Holdings Inc
$ 27.42
(1.86%)
89.54M

RIGL Discussion

View Posts
dcaf7 dcaf7 7 months ago
Titles of olutasidenib presentations at ASCO:
1. Safety and efficacy of olutasidenib treatment in elderly patients with relapsed/refractory mIDH1 acute myeloid leukemia.
2. Patients with relapsed/refractory mIDH1 AML who proceeded to transplant after olutasidenib treatment.
3. Olutasidenib for mutated IDH1 acute myeloid leukemia: Final five-year results from the phase 2 pivotal cohort.
πŸ‘οΈ0
Monksdream Monksdream 7 months ago
RIGL under $2
πŸ‘οΈ0
Monksdream Monksdream 8 months ago
RIGL under $2
πŸ‘οΈ0
dcaf7 dcaf7 8 months ago
Just published, "Olutasidenib in post-venetoclax patients with mutant isocitrate dehydrogenase 1 (mIDH1) acute myeloid leukemia (AML)". The results of this phase 2 study support data from registrational cohort demonstrating that Olutasidenib works well in patients previously treated with venetoclax.
https://pubmed.ncbi.nlm.nih.gov/38538632/
πŸ‘οΈ0
dcaf7 dcaf7 8 months ago
Good read on Olutasidenib
https://journals.lww.com/oncology-times/fulltext/2024/03000/olutasidenib_as_a_breakthrough_for_r_r_midh1_aml.25.aspx
Important further research: 1) studying whether olutasidenib can eliminate the stem cell fraction within each patient's IDH1-mutant AML; 2) characterization of synthetic lethality involving olutasidenib in IDH1-mutant AML.
πŸ‘οΈ0
dcaf7 dcaf7 9 months ago
Rigel Pharmaceuticals Acquires U.S. Rights to GAVRETO®
FEBRUARY 22, 2024 7:50AM EST
GAVRETO® (pralsetinib) is an FDA approved targeted therapy for the treatment of RET fusion-positive metastatic non-small cell lung cancer and advanced or metastatic thyroid cancer
Acquisition of established U.S. marketed product further expands Rigel's portfolio and leverages Rigel's existing infrastructure in both the institutional and community settings
GAVRETO generated ~$28M in U.S. net product sales in 2023
πŸ‘οΈ0
bme bme 1 year ago
Rigl should be VTGN (Today) one day.
πŸ‘οΈ0
bme bme 1 year ago
Yeah. Should be good Q.
πŸ‘οΈ0
TucsonPhil TucsonPhil 1 year ago
Hopefully, the inducement grants are being used to hire qualified talent, rather than pad the wallets of friends and relatives.
πŸ‘οΈ0
bme bme 1 year ago
Better be good.
πŸ‘οΈ0
bme bme 1 year ago
Ugly.
πŸ‘οΈ0
The Night Stalker The Night Stalker 1 year ago
nice
πŸ‘οΈ0
The Night Stalker The Night Stalker 1 year ago
nice
πŸ‘οΈ0
The Night Stalker The Night Stalker 1 year ago
base
πŸ‘οΈ0
bme bme 1 year ago
What a shoot! Amazing.
πŸ‘οΈ0
bme bme 1 year ago
The next quarter fin should include the rev for TAVALISSE. "In April, Rigel's partner Kissei announced the launch of TAVALISSE in Japan for the treatment of chronic ITP."
1. What else should we expect as for the rev?
2. Result of phase 3 of Fostamatinib3 COVID 19?
3. Status of Fostamatinib-ACTIV4 COVID 19?
4. Partnered Programs?
πŸ‘οΈ0
The Night Stalker The Night Stalker 1 year ago
nice fins
πŸ‘οΈ0
The Night Stalker The Night Stalker 1 year ago
gem
πŸ‘οΈ0
The Night Stalker The Night Stalker 1 year ago
gem
πŸ‘οΈ0
The Night Stalker The Night Stalker 1 year ago
easy
πŸ‘οΈ0
bme bme 1 year ago
Nice spike AH today.
πŸ‘οΈ0
bme bme 1 year ago
Higher low higher low.... next leg is North.
πŸ‘οΈ0
The Night Stalker The Night Stalker 1 year ago
https://www.barchart.com/stocks/quotes/RIGL/technical-chart?plot=BAR&volume=total&data=I:120&density=H120&pricesOn=1&asPctChange=0&logscale=0&im=120&indicators=EXPMA(9);SMA(20);BBANDS(20,2);MACD(12,26,9)&sym=RIGL&grid=1&height=500&studyheight=100
πŸ‘οΈ0
The Night Stalker The Night Stalker 1 year ago
https://www.barchart.com/stocks/quotes/RIGL/technical-chart?plot=BAR&volume=total&data=I:120&density=H120&pricesOn=1&asPctChange=0&logscale=0&im=120&indicators=EXPMA(9);SMA(20);BBANDS(20,2);MACD(12,26,9)&sym=RIGL&grid=1&height=500&studyheight=100
πŸ‘οΈ0
bme bme 1 year ago
acting wild atm, but still healthy.
πŸ‘οΈ0
The Night Stalker The Night Stalker 1 year ago
nice
πŸ‘οΈ0
bme bme 1 year ago
Nice & Healthy.
πŸ‘οΈ0
The Night Stalker The Night Stalker 2 years ago
quite the dip
πŸ‘οΈ0
The Night Stalker The Night Stalker 2 years ago
ready
πŸ‘οΈ0
The Night Stalker The Night Stalker 2 years ago
ready
πŸ‘οΈ0
The Night Stalker The Night Stalker 2 years ago
red to green
πŸ‘οΈ0
The Night Stalker The Night Stalker 2 years ago
red to green
πŸ‘οΈ0
bme bme 2 years ago
Wonderful!
πŸ‘οΈ0
The Night Stalker The Night Stalker 2 years ago
beauty
πŸ‘οΈ0
The Night Stalker The Night Stalker 2 years ago
nice
πŸ‘οΈ0
bme bme 2 years ago
Expect Q4 filing this week?
πŸ‘οΈ0
bme bme 2 years ago
Be seeing that. Lot of 1.95 transactions so far
πŸ‘οΈ0
TucsonPhil TucsonPhil 2 years ago
Revenue potential appears good. SP is slowly rising, and looks like it has been in accumulation for the past few weeks.
πŸ‘οΈ0
bme bme 2 years ago
SP should be a lot higher since the Q4 revenue is more than double from last year...
πŸ‘οΈ0
Welldoctor Welldoctor 2 years ago
Apparently insider buying reported on ST. Take it for what it’s worth.
πŸ‘οΈ0
Welldoctor Welldoctor 2 years ago
RIGL news out
πŸ‘οΈ0
bme bme 2 years ago
Looks like it will poke thru & bye bye 1 today.
πŸ‘οΈ0
doesitreallymatter doesitreallymatter 2 years ago
Just like ABQQ. Right?
πŸ‘οΈ0
subslover subslover 2 years ago
You are 1/2 way there!!!!
πŸ‘οΈ0
KngmAz KngmAz 2 years ago
Wow - BOOM - we just went over a dollar - next step $10.00 - DON'T MISS OUT!!
πŸ‘οΈ0
KngmAz KngmAz 2 years ago
This is a $10.00 per share stock in the very near future - EASILY!!
πŸ‘οΈ0
Alaska40 Alaska40 2 years ago
I just bought in. Seems like a good run could come in the near future.
πŸ‘οΈ0
subslover subslover 2 years ago
Consolidating nicely on Continuation from last week!
πŸ‘οΈ0
bcapps66 bcapps66 2 years ago
LOL!
πŸ‘οΈ0
THEMASTERS_SON THEMASTERS_SON 2 years ago
GIVE ME MY $2DOLLAS…YA BUM
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock